Ligand validation:2ORK

IPD: D-MYO-INOSITOL-1-PHOSPHATE

IPD is a Ligand Of Interest in 2ORK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ORK_IPD_C_995	69%	62%	0.12	0.934	0.57	0.86	-	1	0	0	100%	0.925
2ORK_IPD_B_995	48%	58%	0.154	0.896	0.7	0.92	-	-	0	0	100%	0.925
3IKP_IPD_B_405	51%	50%	0.125	0.877	1.44	0.51	3	-	0	0	100%	1
1AWB_IPD_B_1	93%	56%	0.086	0.983	1.02	0.69	-	-	0	0	100%	1
8WDQ_IPD_B_302	90%	44%	0.07	0.953	1.11	1.06	1	1	0	0	100%	1
5J16_IPD_B_303	89%	32%	0.089	0.968	1.59	1.13	5	1	0	0	100%	0.8812
5F24_IPD_A_306	87%	30%	0.108	0.979	0.86	1.89	1	6	0	0	100%	1
1G0H_IPD_A_292	56%	54%	0.171	0.944	1.16	0.65	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.